Cytokines such as interleukin (IL)-2, IL-4, IL-12 and others dramatically influence the immune response and therefore understanding the molecular basis of cytokine signal transduction should provide important insights into lymphocyte activation. To this end, we cloned a protein tyrosine kinase, JAK3 that is a critical element in signaling via the subfamiy of cytokine (IL-2, IL-4, IL-7, IL-9, and IL15) receptors that use the common gamma chain (gamma-c). The discovery that mutations of gamma-c are the molecular basis of X-linked severe combined immunodeficiency(X-SCID), let us map the JAK3 locus to chromosome 19 and then to identify patients with autosomal SCID that is due to mutations of JAK3 itself indicating that JAK3 and its function are critical in the development of the immune system. We went on to furtuer characterize the consequence of JAK3 deficiency in terms of signaling by different gamma-c using cytokines. Specifically, we showed that IL-2 signaling is severely impaired by JAK3 deficiency whereas IL-4 is only partially impaired. These findings were confirmed by analyzing signaling in cells from patients with XSCID, i.e., gamma-c deficiency; together they indicate the existence of a gamma-c/JAK3 independent signaling pathway for IL-4, a finding that may have important implications in the pathogenesis of these diseases. We further showed that these cellular defects can be corrected retroviral gene transduction. We also sequenced the JAK3 gene to facilitate the identification of other JAK3 deficient patients. We have also investigated IL-12 signal transduction and demonstrated that it involves the kinases JAK2 and TYK2 and the STAT4 transcription factor. We also have shown that IL-12 induces serine as well as tyrosine phosphorylation of STAT4 and this appears to be important for transactivation. It is hoped that understanding the precise mechanisms involved in cytokine signaling will provide avenues for the development of novels agents that can regulate the immune response in a therapeutically desirable manner.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Intramural Research (Z01)
Project #
1Z01AR041106-02
Application #
2568377
Study Section
Special Emphasis Panel (ARB)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chen, Zhi; O'Shea, John J (2008) Regulation of IL-17 production in human lymphocytes. Cytokine 41:71-8
O'Shea, John J; Murray, Peter J (2008) Cytokine signaling modules in inflammatory responses. Immunity 28:477-87
Park, Heiyoung; Teja, Kabir; O'Shea, John J et al. (2007) The Yersinia effector protein YpkA induces apoptosis independently of actin depolymerization. J Immunol 178:6426-34
Li, Hongjie; Watford, Wendy; Li, Cuiling et al. (2007) Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest 117:1314-23
Laurence, Arian; O'Shea, John J (2007) T(H)-17 differentiation: of mice and men. Nat Immunol 8:903-5
Chen, Zhi; Tato, Cristina M; Muul, Linda et al. (2007) Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56:2936-46
Liu, Eric H; Siegel, Richard M; Harlan, David M et al. (2007) T cell-directed therapies: lessons learned and future prospects. Nat Immunol 8:25-30
Ramos, Haydee L; O'Shea, John J; Watford, Wendy T (2007) STAT5 isoforms: controversies and clarifications. Biochem J 404:e1-2
Laurence, Arian; Tato, Cristina M; Davidson, Todd S et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371-81
Yao, Zhengju; Kanno, Yuka; Kerenyi, Marc et al. (2007) Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109:4368-75

Showing the most recent 10 out of 84 publications